is skyrizi a glp 1 AbbVie breaks new ground for IL-23 drug in IBD Frontiers | GLP-1 receptor agonists
Description
In this post, Ill share with you some of the plotline for our discussion
On reflection, we come to realize that Scott Galloways observation about the drug category profoundly impacting society and the macro-economy was spot-on and prescient.
Eligibility criteria for selecting studies Eligible randomised controlled trials enrolled adults with type 2 diabetes who received GLP-1RA treatments and compared effects with placebo or any GLP-1RA drug, with a follow-up duration of at least 12 weeks
Behind the trend is the surging popularity of GLP-1 weight loss medications, a class of so-called peptides approved to help users quickly shed pounds.
A phase 2 trial of Retatrutide (TripleHormone-Receptor Agonist) for obesity
